Trials for colitis: An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.
Answered 7/5/2012
5.8k views
Trials for colitis: An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.
Answered 3/31/2013
5.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question